English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduRush University Medical Center will require all staff, contractors and volunteers to be fully vaccinated for COVID-19 by October 1.
Tag: COVID-19 Vaccine
National Poll: Parents split on whether to vaccinate younger kids against COVID
Many parents are missing opportunities to discuss questions and concerns about the COVID vaccine for kids with a doctor.
10 reasons to put the COVID-19 vaccine on your back-to-school list
Starting the COVID-19 vaccination process in July and August can prepare teens and young adults for a safe school year and protect children who can’t be vaccinated.
No Sign of COVID-19 Vaccine in Breast Milk
Messenger RNA vaccines against COVID-19 were not detected in human milk, according to a small study by UC San Francisco, providing early evidence that the vaccine mRNA is not transferred to the infant.
COVID-19 Vaccine Protection Against Infection Lower and Slower in People with Liver Disease
A study shows for the first time that people with cirrhosis who receive mRNA COVID-19 vaccination gain important protection against more serious outcomes like hospitalization and death. At the same time, however, the vaccines offer less protection against SARS-CoV-2 infection and take longer to take effect in this population.
Phage Display-Based Gene Delivery: A Viable Platform Technology for COVID-19 Vaccine Design and Development
Researchers at Rutgers Cancer Institute of New Jersey, Rutgers New Jersey Medical School (NJMS) and the Center for Theoretical Biological Physics (CTBP) at Rice University in Houston, Texas, have demonstrated that a technology with favorable biological attributes known as phage display could be a viable platform for the development of new vaccines to protect against COVID-19.
mRNA Vaccines Slash Risk of COVID-19 Infection by 91 Percent in Fully Vaccinated People
People who receive mRNA COVID-19 vaccines are up to 91 percent less likely to develop the disease than those who are unvaccinated, according to a new nationwide study of eight sites, including Salt Lake City. For those few vaccinated people who do still get an infection, or “breakthrough” cases, the study suggests that vaccines reduce the severity of COVID-19 symptoms and shorten its duration.
GW Experts Available to Discuss Returning to the Office This Fall
WASHINGTON (June 30, 2021) — Now that COVID-19 vaccination rates in the United States have gone way up, many employers are calling workers back to the office. However, surveys show that many employees enjoy working from home and do not want…
Rutgers Chancellor Available to Discuss the Need for Health Care Workers to be Vaccinated Against COVID-19
Brian L. Strom, chancellor at the Rutgers Biomedical and Health Sciences and executive vice president for Rutgers Health Affairs is available to discuss why it’s important for health care and public safety workers to get vaccinated against COVID-19, as the…
COVID-19 Vaccine Hesitancy: Dr. Vin Gupta Narrates New American Thoracic Society Video
The American Thoracic Society rolls out a new video to address vaccine hesitancy and answer common questions amid the COVID-19 pandemic.
University of Miami Miller School Study Shows COVID-19 mRNA Vaccines Do Not Impact Male Fertility
The Pfizer and Moderna mRNA COVID-19 vaccines is safe for male reproduction, according to a new study by University of Miami Miller School of Medicine researchers published in JAMA , the most widely circulated general medical journal in the world.
Data and safety review board reports how it monitored the COVID-19 vaccine trials
Evaluation of three vaccine candidates during the COVID-19 pandemic fell to 12 experts of the federally appointed COVID-19 Vaccine Data and Safety Monitoring Board. This team has now taken the unusual step of publishing details of their review process in The Journal of Infectious Diseases.
Dollars to donuts: What will it take to get more of the U.S. vaccinated against COVID-19?
Prizes, lotteries, discounts and freebies for COVID-19 vaccination may help overcome vaccine hesitancy and reward the vaccinated too, but it’s important to learn from this moment to inform other preventive health care, an expert says.
FSU expert available to discuss vaccine hesitancy
By: Bill Wellock | Published: June 2, 2021 | 1:16 pm | SHARE: Rollout of the COVID-19 vaccine is continuing, but some people are hesitant to get vaccinated against the disease.Dr. Christie Alexander, an associate professor in the Department of Family Medicine and Rural Health in the Florida State University College of Medicine and a past president of the Florida Academy of Family Physicians, recently participated in an expert panel about how to win over vaccine skeptics.
Safety board members describe stringent oversight of U.S. COVID-19 vaccine trials
In a new report published in the Journal of Infectious Diseases, the 11-member Data and Safety Monitoring Board (DSMB) that is overseeing the federally funded COVID-19 vaccine trials outlines its mission, procedures, and the challenges that it faced in monitoring…
Why are some Covid-19 vaccines working better for men than women?
If there’s one take-home message for the general public about the coronavirus vaccines approved in the U.S., it’s that they are remarkably effective. But Michigan State University’s Morteza Mahmoudi is raising awareness about an important subtlety: The vaccines developed by Moderna and Pfizer-BioNTech appear to work slightly better for men than for women.
Researchers Call for More Transparency from Russia’s Sputnik COVID Vaccine
“It is not a problem connected to “the Sputnik V” vaccine itself,” argues Prof. Enrico Bucci, adjunct professor in the Department of Biology, Temple University, and part of the Sbarro Health Research Organization (SHRO).
Rush Collaborates With Malcolm X College to Train COVID-19 Vaccine Ambassadors
Rush staff members collaborated with Malcom X College to provide content including video scenarios and conversation advice, for a new Vaccine Ambassador Course offered to the public.
Rutgers Expert Available to Discuss Waiving COVID-19 Vaccine Patents to Increase Global Vaccinations
Rutgers global health expert Richard Marlink is available to discuss the waiving of vaccine patents to help increase global vaccination rates in less developed countries — a move the Biden administration recently supported ahead of negotiations with the World Trade…
COVID-19 vaccine: Understanding herd immunity, vaccine hesitancy
Since the beginning of the pandemic, herd immunity has been portrayed as the holy grail to overcome the COVID-19 pandemic.
Rutgers Expert Available to Discuss FDA Preparing to Expand Use of Pfizer’s Coronavirus Vaccine to Adolescents as Young as 12 by Next Week
Stanley H. Weiss, an epidemiologist in infectious and chronic diseases and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health available for media interviews to discuss the FDA preparing to expand use of…
Rutgers Expert Available to Discuss FDA Preparing to Expand Use of Pfizer’s Coronavirus Vaccine to Adolescents as Young as 12 by Next Week
Stanley H. Weiss, an epidemiologist in infectious and chronic diseases and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health available for media interviews to discuss the FDA preparing to expand use of…
Rutgers Expert Available to Discuss FDA Preparing to Expand Use of Pfizer’s Coronavirus Vaccine to Adolescents as Young as 12 by Next Week
Stanley H. Weiss, an epidemiologist in infectious and chronic diseases and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health available for media interviews to discuss the FDA preparing to expand use of…
Rutgers Expert Available to Discuss FDA Preparing to Expand Use of Pfizer’s Coronavirus Vaccine to Adolescents as Young as 12 by Next Week
Stanley H. Weiss, an epidemiologist in infectious and chronic diseases and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health available for media interviews to discuss the FDA preparing to expand use of…
Rutgers Expert Available to Discuss FDA Preparing to Expand Use of Pfizer’s Coronavirus Vaccine to Adolescents as Young as 12 by Next Week
Stanley H. Weiss, an epidemiologist in infectious and chronic diseases and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health available for media interviews to discuss the FDA preparing to expand use of…
Rutgers Expert Available to Discuss FDA Preparing to Expand Use of Pfizer’s Coronavirus Vaccine to Adolescents as Young as 12 by Next Week
Stanley H. Weiss, an epidemiologist in infectious and chronic diseases and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health available for media interviews to discuss the FDA preparing to expand use of…
Rutgers Expert Available to Discuss FDA Preparing to Expand Use of Pfizer’s Coronavirus Vaccine to Adolescents as Young as 12 by Next Week
Stanley H. Weiss, an epidemiologist in infectious and chronic diseases and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health available for media interviews to discuss the FDA preparing to expand use of…
Rutgers Expert Available to Discuss FDA Preparing to Expand Use of Pfizer’s Coronavirus Vaccine to Adolescents as Young as 12 by Next Week
Stanley H. Weiss, an epidemiologist in infectious and chronic diseases and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health available for media interviews to discuss the FDA preparing to expand use of…
Rutgers Expert Available to Discuss Dangers of Missing Second Doses of COVID-19 Vaccines
Rutgers scholar Stanley H. Weiss is available to discuss the trend of people skipping their second dose of COVID-19 vaccines and how this delays herd immunity. “The second shot leads to a huge boost of the body’s immune protection –…
Who Has a Right to Ask if You’re Vaccinated?
COVID-19 vaccination has become a lightning rod for controversy over “vaccine passports” and claims of violations of medical privacy or individual rights. But as two experts explain, there’s a long history of efforts to protect the health of others by requiring individuals to provide proof of vaccination or of a past infection, or seek a medical or religious exception.
‘There Is a Job for Everyone, Even Opening Band-Aids’
A 7-year-old patient at Rush University Children’s Hospital named Kashton has been helping get band-aids for the vaccine clinic ready, alongside one of his nurses. Together, they’ve opened hundreds.
Leading US hospitals team up to promote COVID-19 vaccination
A coalition of 60 top hospitals and health care institutions have joined forces in a nationwide campaign to encourage adults to get vaccinated against COVID-19. Led by Cleveland Clinic and Mayo Clinic, the campaign “Get the Vaccine to Save Lives” is designed to reassure the public that vaccines are safe, effective and necessary to achieve herd immunity and return to normal activities.
Forum Tackles Vaccine Hesitancy in the Black Community
Leading healthcare and faith leaders addressed key issues that are contributing to vaccine hesitancy in Black communities during a national online discussion this week, explaining that a lack of access to healthcare, concerns over vaccine safety, and religious beliefs are keeping many from getting COVID-19 vaccines.
Patients of women doctors more likely to be vaccinated against the flu
Elderly patients of female physicians are more likely than those of male physicians in the same outpatient practice to be vaccinated against the flu. This trend holds for all racial and ethnic groups studied and could provide insight into improving vaccination rates for influenza, COVID-19 and other illnesses
6 important things to know about your COVID-19 vaccine card
Everyone who gets vaccinated for COVID-19 in the U.S. receives a vaccine card. Sarah Lynch, clinical assistant professor of pharmacy practice at Binghamton University, State University of New York, offers insight into why vaccine cards are important and why you…
Tip Sheet: New COVID-19 transmission study, returning to school, video of biorepositories — and a new weight loss study
SEATTLE — April 2, 2021 — Below are summaries of recent Fred Hutch research findings and other news. April is National Minority Health Month, with a focus on the disproportionate impacts of COVID-19 on communities of color. See more details below on related Fred Hutch programming.Save the date for our monthly public science event, “Science Says” on Tuesday, April 27.
The Medical Minute: Proceed with caution even after vaccination
More and more Americans are becoming vaccinated against COVID-19, but headlines warn that the number of cases is rising. What’s up with that?
Twenty-four States Have Implemented Temporary, Emergency Policies Expanding the COVID-19 Vaccinator Workforce Beyond Traditional Clinical Personnel
The vaccinator workforce is an essential component of the COVID-19 response and recovery. However, since administration of the two FDA-authorized COVID-19 vaccines began in December 2020, the rollout has encountered several challenges and failed to meet initial targets for total vaccinations provided. The current health workforce has been identified as one possible bottleneck for distributing the vaccine, prompting a general call to authorize as many healthcare professionals to administer the vaccine as possible. To track this fast-moving issue at the state level, researchers at the Fitzhugh Mullan Institute for Health Workforce Equity have created an interactive tool that displays temporary, emergency state policies authorizing specific professions to provide the COVID-19 vaccine.
Your Questions, Answered: Examining Mistrust and Vaccines
On Feb. 22, the University of California San Diego brought together a panel of industry experts and esteemed faculty to kick off the university’s “Evenings of Nonconventional Wisdom” online event series hosted in celebration of the university’s 60th anniversary. To continue the timely dialogue around COVID-19 and vaccines, we reached back out to a few of the event panelists plus a leader from UC San Diego’s Return to Learn Program Dr. Robert “Chip” Schooley to answer questions submitted by the audience.
“Unlock the Science” Series
With topics ranging from the food we eat, the air we breathe, and the land we dwell on to the health of our body and mind, and the well-being of all things in the universe, this is a program that is for everyone and anyone. So, stay tuned and listen LIVE on Chula Radio Plus
Patients, Prescriptions and the COVID-19 Vaccine
As the COVID-19 vaccine becomes more readily available to people across the country, many patients living with multiple sclerosis (MS), an often debilitating autoimmune disease of the central nervous system, are questioning whether patients on certain medications should get the shot.
Big shift seen in high-risk older adults’ attitudes toward COVID-19 vaccination
Last fall, many older adults were on the fence about getting a COVID-19 vaccine, according to a poll taken in October. But a new poll taken in late January shows a large uptick in positive attitudes, including among people over 50 who are Black, Hispanic or in fair or poor health.
“Video: Should I get the COVID-19 if I have an autoimmune disease?”
The approval of COVID-19 vaccines has brought with it hope, excitement, as well as concerns. AARDA is committed to ensuring you have the information you need to make the right decisions for your health. A panel of medical experts will discuss frequently asked questions regarding COVID-19 vaccines, as well as address audience questions.
More than 2/3 of Indiana nursing home staff would take COVID-19 vaccine
In a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future.
Behind the Scenes at a COVID-19 Vaccine Trial
The principal investigators of the Moderna and Johnson & Johnson COVID-19 vaccine clinical trials at Rutgers discuss how the university became a site and their challenges and successes. The Rutgers J&J trial site was the second-largest clinical trial for the company.
‘Immunity passports’ for COVID-19 must be distributed equitably
Proof of vaccination against COVID-19 i.e. “immunity passports” promise a way to return to a more normal social and economic life, but the benefits they generate will be dispersed unequally, and it is not obvious that they are ethical, according…
Rutgers Expert Available to Comment on Delay in COVID-19 Vaccination Booster
With scheduling and shipment problems and bad weather delaying second doses of the COVID-19 vaccination, Rutgers scholar Reynold Panettieri is available to discuss the efficacy of the second dose if it is not administered exactly at the 21-day mark for…
An epidemiologist breaks down the numbers on Johnson & Johnson’s single-dose vaccine
While the Johnson & Johnson single-dose COVID-19 vaccine that has now received emergency use authorization by the U.S. Food and Drug Administration has a lower efficacy rate compared to other previously approved vaccines, an expert with The University of Texas Health Science Center at Houston (UTHealth) explains why it is still a significant step toward ending the COVID-19 pandemic.
Why COVID-19 vaccine distribution methods fall short and 3 ways to improve them
Several proposals have emerged on how to distribute the COVID-19 vaccine, but they fall short in ensuring that the vaccine is distributed fairly. A team including Binghamton University professor Nicole Hassoun suggests three ways to more fairly and effectively distribute the vaccine so that people in poor countries get the vaccine as soon as possible.
George Washington University to Participate in Sanofi COVID-19 Vaccine Trial
The George Washington University is a site for a phase 2 clinical trial for Sanofi’s adjuvanted recombinant protein-based COVID-19 vaccine candidate.